{
  "id": "5c928958ecadf2e73f000017",
  "type": "list",
  "question": "List the four advances integrated into the SHERLOCKv2 platform.",
  "ideal_answer": "SHERLOCKv2 presents with four distinct advances: (i) four-channel single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement of input as low as 2 attomolar; (iii) 3.5-fold increase in signal sensitivity by combining Cas13 with Csm6, an auxiliary CRISPR-associated enzyme; and (iv) lateral-flow readout.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29449508"
  ],
  "snippets": [
    {
      "text": "Through characterization of CRISPR enzymology and application development, we report here four advances integrated into SHERLOCK version 2 (SHERLOCKv2) (i) four-channel single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement of input as low as 2 attomolar; (iii) 3.5-fold increase in signal sensitivity by combining Cas13 with Csm6, an auxiliary CRISPR-associated enzyme; and (iv) lateral-flow readout. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29449508",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "four-channel single-reaction multiplexing with orthogonal CRISPR enzymes, quantitative measurement of input as low as 2 attomolar, 3.5-fold increase in signal sensitivity by combining Cas13 with Csm6, an auxiliary CRISPR-associated enzyme, lateral-flow readout"
}